Related Experiment Video
Updated: Apr 28, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.1K
Management options for established chemotherapy-induced peripheral neuropathy
Deirdre R Pachman1, James C Watson, Maryam B Lustberg
1Division of Medical Oncology, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA, pachman.deirdre@mayo.edu.
Summary
Chemotherapy-induced peripheral neuropathy (CIPN) significantly impacts cancer patients. This review synthesizes evidence for CIPN and non-CIPN treatments to guide clinical practice.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent, disabling side effect of cancer treatment.
- CIPN negatively affects patient quality of life, psychosocial well-being, and treatment adherence.
- Current treatment strategies often lack robust evidence specific to CIPN.
Purpose of the Study:
- To review and synthesize existing evidence for treating CIPN.
- To examine treatment options for non-CIPN peripheral neuropathies.
- To develop a practical, evidence-based approach for managing CIPN.
Main Methods:
- Comprehensive literature search for CIPN and non-CIPN treatment studies.
- Critical appraisal of evidence quality for various interventions.
- Integration of research findings with clinical experience.
Main Results:
- Limited high-quality evidence exists for many CIPN interventions.
- Evidence from non-CIPN neuropathies is often extrapolated to CIPN.
- A practical treatment framework requires careful consideration of available data.
Conclusions:
- A systematic approach to CIPN management is needed.
- Further research is crucial to establish effective CIPN treatments.
- Evidence-based guidelines can improve patient outcomes and quality of life.
Related Concept Videos
01:26Peripheral Artery Disease IV: Nursing Management
699
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
699
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
816
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
816
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
01:23Peripheral Artery Disease V: Postoperative Nursing Management
629
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
629
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
920
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
920
01:27Peripheral Artery Disease III: Interprofessional Care
653
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653